Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + tetracycline vs vonoprazan + amoxicillin for Helicobacter pylori eradication
ChiCTR2600122530Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: eradication rate of Helicobacter pylori. Started Apr 2026; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2600122530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122530.